HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

4'- (4,4- difluoro- 5- (2- oxo- 2- (4- piperidinopiperidino)ethylidene)- 2,3,4,5- tetrahydro- 1H- 1- benzoazepine- 1- carbonyl)- 2- methyl- 3- furanilide

a vasopressin V(1A) receptor antagonist; structure in first source
Also Known As:
(Z)-4'-(4,4-difluoro-5-(2-oxo-2-(4-piperidinopiperidino)ethylidene)-2,3,4,5-tetrahydro-1H-1-benzoazepine-1-carbonyl)-2-methyl-3-furanilide hemifumarate; YM 218; YM-218; YM218
Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Tomura, Yuichi: 3 articles (06/2007 - 01/2006)
2. Tsukada, Junko: 3 articles (06/2007 - 01/2006)
3. Shibasaki, Masayuki: 3 articles (06/2007 - 01/2006)
4. Yatsu, Takeyuki: 3 articles (06/2007 - 01/2006)
5. Suzuki, Takeshi: 3 articles (06/2007 - 01/2006)
6. Tahara, Atsuo: 3 articles (06/2007 - 01/2006)
7. Momose, Kazuhiro: 2 articles (05/2006 - 01/2006)
8. Kluppel, Alex C A: 1 article (12/2006)
9. Henning, Robert H: 1 article (12/2006)
10. van Dokkum, Richard P E: 1 article (12/2006)

Related Diseases

1. Hyperplasia
2. Hypertrophy
3. Proteinuria
4. Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)

Related Drugs and Biologics

1. Vasopressins (Vasopressin)
2. Phosphotransferases (Kinase)
3. Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)

Related Therapies and Procedures

1. Nephrectomy